Utilized for glaucoma and eyelash hypotrichosis to manage intraocular pressure and support follicle growth.
Mechanism of Action
Bimatoprost mimics natural prostamides to increase the outflow of aqueous humor through both the trabecular meshwork and uveoscleral pathways. For eyelashes, it increases the duration of the anagen phase.
Route of Administration
Ophthalmic
Onset Time
4–8 hours
Duration
24 hours
Contraindications
Hypersensitivity to bimatoprost
Severe Adverse Events
Uveitis, Macular edema, Anaphylaxis — requires immediate medical attention
Common Side Effects
Eye redness, Itchy eyes, Blurred vision
Uncommon Side Effects
Iris color change, Eyelash growth, Skin hyperpigmentation
Drug Interactions
Alcohol, Latanoprost, Travoprost
Pregnancy Safety Warnings
FDA Category C: Use with caution. Breastfeeding: Not known if excreted in milk; compatible with caution.
Age Restrictions
Safety and efficacy established in pediatric patients 16 years and older.
Information related to Bimatoprost 0.03% is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
